Close Menu

NEW YORK – NantHealth said Thursday after the close of the market that it posted a marginal year-over-year increase in its third quarter revenues. 

For the three months ended Sept. 30, the Culver City, California-based company recorded revenues of $22.4 million, compared to $22.3 million in Q3 2018.

However, NantHealth said that it became cash flow-positive for the first time during the quarter. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.